The putative role of oncogenic missense mutations in NUTM1 in CCA pathogeneisis is unclear, however a recent report supports a model wherehistone hyperacetylation initiates transcriptional activation, which underlies oncogenesis in NMC44. This evidence concerns the gene NUTM1 and cholangiocarcinoma.